193.88
36.84 (23.46%)
| Previous Close | 157.04 |
| Open | 169.28 |
| Volume | 2,940,888 |
| Avg. Volume (3M) | 874,280 |
| Market Cap | 12,444,187,648 |
| Price / Earnings (TTM) | 18.70 |
| Price / Earnings (Forward) | 11.35 |
| Price / Sales | 1.06 |
| Price / Book | 91.65 |
| 52 Weeks Range | |
| Earnings Date | 5 Aug 2026 |
| Profit Margin | 6.63% |
| Operating Margin (TTM) | 13.44% |
| Diluted EPS (TTM) | 10.08 |
| Quarterly Revenue Growth (YOY) | 5.00% |
| Quarterly Earnings Growth (YOY) | -32.00% |
| Total Debt/Equity (MRQ) | 742.20% |
| Current Ratio (MRQ) | 1.25 |
| Operating Cash Flow (TTM) | 2.34 B |
| Levered Free Cash Flow (TTM) | 1.58 B |
| Return on Assets (TTM) | 7.04% |
| Return on Equity (TTM) | 54.79% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Bullish |
| Medical Care Facilities (Global) | Bullish | Bullish | |
| Stock | DaVita Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | -5.0 |
| Price Volatility | -3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | -0.40 |
|
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Core |
| % Held by Insiders | 49.51% |
| % Held by Institutions | 48.76% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| ACKERMAN JOEL | - | 196.26 | -51,471 | -10,101,698 |
| BERKSHIRE HATHAWAY INC | - | 151.65 | -1,220,376 | -185,070,020 |
| HEARTY JAMES O | - | 193.88 | -2,184 | -423,434 |
| Aggregate Net Quantity | -1,274,031 | |||
| Aggregate Net Value ($) | -195,595,153 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 180.60 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| ACKERMAN JOEL | Officer | 07 May 2026 | Sell (-) | 51,471 | 196.26 | 10,101,698 |
| HEARTY JAMES O | Officer | 06 May 2026 | Automatic sell (-) | 2,184 | 193.88 | 423,434 |
| BERKSHIRE HATHAWAY INC | 01 May 2026 | Sell (-) | 1,220,376 | 151.65 | 185,070,020 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |